Detection of Airway Colonization by Aspergillus fumigatus by Use of Electronic Nose Technology in Patients with Cystic Fibrosis
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Currently, there is no noninvasive test that can reliably diagnose early invasive pulmonary aspergillosis (IA). An electronic nose (eNose) can discriminate various lung diseases through an analysis of exhaled volatile organic compounds. We recently published a proof-of-principle study showing that patients with prolonged chemotherapy-induced neutropenia and IA have a distinct exhaled breath profile (or breathprint) that can be discriminated with an eNose. An eNose is cheap and noninvasive, and it yields results within minutes. We determined whether Aspergillus fumigatus colonization may also be detected with an eNose in cystic fibrosis (CF) patients. Exhaled breath samples of 27 CF patients were analyzed with a Cyranose 320. Culture of sputum samples defined the A. fumigatus colonization status. eNose data were classified using canonical discriminant analysis after principal component reduction. Our primary outcome was cross-validated accuracy, defined as the percentage of correctly classified subjects using the leave-one-out method. The P value was calculated by the generation of 100,000 random alternative classifications. Nine of the 27 subjects were colonized by A. fumigatus . In total, 3 subjects were misclassified, resulting in a cross-validated accuracy of the Cyranose detecting IA of 89% ( P = 0.004; sensitivity, 78%; specificity, 94%). Receiver operating characteristic (ROC) curve analysis showed an area under the curve (AUC) of 0.89. The results indicate that A. fumigatus colonization leads to a distinctive breathprint in CF patients. The present proof-of-concept data merit external validation and monitoring studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cornillet, A., Camus, C., Nimubona, S., Gandemer, V., Tattevin, P., Belleguic, C., Chevrier, S., Meunier, C., Lebert, C., Aupee, M., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/505870 · Cited by 361
A Breath Fungal Secondary Metabolite Signature to Diagnose Invasive Aspergillosis
Koo, S., Thomas, H. R., Daniels, S. D., Lynch, R. C., Fortier, S. M., Shea, M. M., Rearden, P., Comolli, J. C., Baden, L. R., & Marty, F. M. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu725 · Cited by 153
The Volatome of Aspergillus fumigatus
Heddergott, C., Calvo, A. M., & Latgé, J. P. (2014) · Eukaryotic Cell · doi:10.1128/ec.00074-14 · Cited by 113
Cited by
The smell of lung disease: a review of the current status of electronic nose technology
van der Sar, I. G., Wijbenga, N., Nakshbandi, G., Aerts, J. G. J. V., Manintveld, O. C., Wijsenbeek, M. S., Hellemons, M. E., & Moor, C. C. (2021) · Respiratory Research · doi:10.1186/s12931-021-01835-4 · Cited by 87
“De Heer 2016 [54] n = 9 CF colonised A.”
BackgroundResultRecent Advances in Diagnosing Chronic Pulmonary Aspergillosis
Takazono, T., & Izumikawa, K. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01810 · Cited by 71
Special considerations for the diagnosis and treatment of invasive pulmonary aspergillosis
McCarthy, M. W., & Walsh, T. J. (2017) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2017.1340835 · Cited by 8
“leads to a distinctive breathprint [125,127].”
BackgroundBarucha, A., Mauch, R. M., Duckstein, F., Zagoya, C., & Mainz, J. G. (2022) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2022.2104249 · Cited by 6
Metadata
- Authors
- de Heer, K., Kok, M. G. M., Fens, N., Weersink, E. J. M., Zwinderman, A. H., van der Schee, M. P. C., Visser, C. E., van Oers, M. H. J., & Sterk, P. J.
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2016-03
- Volume
- 54
- Issue
- 3
- Pages
- 569-575
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- OpenAlex
- W2235231799
- Cited by
- 53
- References
- 3
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Detection of Airway Colonization by Aspergillus fumigatus by Use of Electronic Nose Technology in Patients with Cystic Fibrosis. https://app.cochat.ai/papers/10.1128/jcm.02214-15
- The paper
- de Heer, K., Kok, M. G. M., Fens, N., Weersink, E. J. M., Zwinderman, A. H., van der Schee, M. P. C., Visser, C. E., van Oers, M. H. J., & Sterk, P. J. (2016). Detection of Airway Colonization by Aspergillus fumigatus by Use of Electronic Nose Technology in Patients with Cystic Fibrosis. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.02214-15
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.